Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis,cirrhosis and fatty liver

Details for Australian Patent Application No. 2001238124 (hide)

Owner New York University

Inventors Chan, Edwin; Cronstein, Bruce N

Agent FB Rice

Pub. Number AU-B-2001238124

PCT Pub. Number WO01/58241

Priority 60/181,546 10.02.00 US

Filing date 12 February 2001

Wipo publication date 20 August 2001

Acceptance publication date 25 May 2006

International Classifications

A61K 31/52 (2006.01)

A61K 31/522 (2006.01)

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/7076 (2006.01)

Event Publications

25 May 2006 Application Accepted

  Published as AU-B-2001238124

21 September 2006 Standard Patent Sealed

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001238125

2001238123